ECSDI055540S - - Google Patents
Info
- Publication number
- ECSDI055540S ECSDI055540S ECSDI055540F ECSDI055540S EC SDI055540 S ECSDI055540 S EC SDI055540S EC SDI055540 F ECSDI055540 F EC SDI055540F EC SDI055540 S ECSDI055540 S EC SDI055540S
- Authority
- EC
- Ecuador
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29/209,646 USD515202S1 (en) | 2004-07-19 | 2004-07-19 | Tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSDI055540S true ECSDI055540S (h) | 2005-04-18 |
Family
ID=35768532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSDI055540 ECSDI055540S (h) | 2004-07-19 | 2005-01-14 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | USD515202S1 (h) |
| AU (1) | AU302423S (h) |
| CA (1) | CA109697S (h) |
| EC (1) | ECSDI055540S (h) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD553733S1 (en) * | 2006-04-07 | 2007-10-23 | Novartis Ag | Tablet |
| USD754840S1 (en) * | 2012-02-03 | 2016-04-26 | Johnson & Johnson Consumer Inc. | Oral dosage form |
| USD754841S1 (en) * | 2012-02-03 | 2016-04-26 | Johnson & Johnson Consumer Inc. | Oral dosage form |
| USD778428S1 (en) * | 2012-02-03 | 2017-02-07 | Johnson & Johnson Consumer Inc. | Oral dosage form |
| USD735315S1 (en) * | 2012-06-25 | 2015-07-28 | Celgene Corporation | Pharmaceutical tablet |
| USD755949S1 (en) * | 2013-07-30 | 2016-05-10 | Reckitt Benckiser Llc | Tablet |
| USD744635S1 (en) * | 2014-06-26 | 2015-12-01 | Access Business Group International Llc | Dietary supplement |
| AU363416S (en) * | 2015-01-22 | 2015-08-13 | Soremartec Sa | Confectionery Product |
| USD907760S1 (en) * | 2017-01-20 | 2021-01-12 | Société des Produits Nestlé S.A. | Orally ingestible tablet |
| USD813372S1 (en) * | 2017-02-22 | 2018-03-20 | Celgene Corporation | Pharmaceutical tablet |
| USD835257S1 (en) * | 2017-02-22 | 2018-12-04 | Celgene Corporation | Pharmaceutical tablet |
| USD1017017S1 (en) * | 2021-12-20 | 2024-03-05 | Pfizer Inc. | Pill |
| USD1071139S1 (en) | 2023-03-13 | 2025-04-15 | Kenvue Brands Llc | Dosage form |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2687367A (en) | 1952-05-05 | 1954-08-24 | Lilly Co Eli | Medicinal tablet containing identification fragments |
| USD258091S (en) | 1978-08-31 | 1981-01-27 | Marion Laboratories, Inc. | Pharmaceutical tablet |
| DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| US4851228A (en) | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic |
| US4693886A (en) | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
| USD304626S (en) | 1987-12-21 | 1989-11-14 | Rorer Pharmaceutical Corporation | Pharmaceutical tablet |
| USD302051S (en) | 1987-12-21 | 1989-07-04 | Rorer Pharmaceutical Corporation | Pharmaceutical tablet |
| USD301764S (en) | 1987-12-21 | 1989-06-20 | Rorer Pharmaceutical Corporation | Pharmaceutical tablet |
| NZ233403A (en) | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
| US5424074A (en) | 1989-06-20 | 1995-06-13 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for potassium supplementation |
| USD316914S (en) | 1989-08-01 | 1991-05-14 | Merrell Dow Pharmaceuticals Inc. | Tablet |
| US5512299A (en) | 1992-03-30 | 1996-04-30 | Alza Corporation | Method of treating oral inflammatory disease |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| USD351464S (en) * | 1992-09-29 | 1994-10-11 | Merck & Co., Inc. | Pharmaceutical product |
| USD375157S (en) | 1992-12-22 | 1996-10-29 | Merck & Co., Inc. | Tablet |
| USD359554S (en) | 1994-02-23 | 1995-06-20 | The Procter & Gamble Company | Tablet |
| USD380825S (en) | 1994-10-31 | 1997-07-08 | Merck & Co., Inc. | Pharmaceutical tablet |
| USD379223S (en) | 1995-09-13 | 1997-05-13 | Merck & Co., Inc. | Pharmaceutical tablet |
| USD400672S (en) | 1996-03-21 | 1998-11-03 | Merck & Co., Inc. | Pharmaceutical tablet |
| USD383535S (en) * | 1996-04-24 | 1997-09-09 | Schering Corporation | Tablet |
| USD423141S (en) * | 1998-03-20 | 2000-04-18 | Colgate-Palmolive Company | Detergent tablet |
| USD428136S (en) * | 1999-04-28 | 2000-07-11 | Hoechst Roussel Vet | Bone shaped tablet |
| USD431076S (en) * | 1999-07-07 | 2000-09-19 | Merck & Co., Inc. | Tablet |
| USD459798S1 (en) * | 2001-03-26 | 2002-07-02 | Aventis Pharma S.A. | Pill tablet |
-
2004
- 2004-07-19 US US29/209,646 patent/USD515202S1/en not_active Expired - Lifetime
-
2005
- 2005-01-10 CA CA 109697 patent/CA109697S/en not_active Expired - Lifetime
- 2005-01-14 EC ECSDI055540 patent/ECSDI055540S/es unknown
- 2005-01-18 AU AU200510190F patent/AU302423S/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU302423S (en) | 2005-07-18 |
| USD515202S1 (en) | 2006-02-14 |
| CA109697S (en) | 2006-05-17 |